Manager TitleAgeSince
Chief Executive Officer - 01/02/2013
Director TitleAgeSince
Director/Board Member - 01/02/2013
Chairman 73 01/12/2015
Date Insider Type Main position Quantity % Market Cap.
9/6/23 A Buy

Director

100,000 0.0350%
2/7/22 A Buy

Director

2,700,000 1.0392%
2/7/22 A Sell

Chief Executive Officer

2,700,000 1.0392%
Logo RHINOMED
Rhinomed Limited is an Australia-based wearable nasal technology company. The Company is engaged in the research, development and commercialization of consumer and medical devices. The Company's products include Mute, Turbine, Pronto Sleep, Pronto Clear and Rhinoswab. Mute dilates the nasal passages making nasal breathing easier, reducing mouth breathing and helping to breathe more, snore less and sleep better. Turbine is designed to fit comfortably inside the nose and gently open each individual nostril to allow more airflow during sport, physical exertion or focused breathing, such as yoga and meditation. Rhinoswab is a patented comfortable, self-administered nasal swab that provides high-yield sampling and fits existing pathology workflows. Pronto Sleep is a vapor inhaler that gently opens the nose and delivers a soothing blend of four pure essential oils. Its nasal platform envisages multiple applications from simple stenting through to nasal drug delivery and sensor/diagnostics.
Employees
-
Sector
-